The Company of Pharmaceutical Industries of Tunisia, SIPHAT, has published its activity indicators for the 2nd quarter of 2019.
At the end of last June, the company achieved a cumulative turnover of about 12.8 million dinars, against 16.7 million a year earlier, i.e. a decrease of 23%. This turnover in the first half represents 25% of the budgeted turnover.
First-half export sales amounted to 222 thousand dinars, down 32% compared to the same period of 2018.
The value of production fell from 16.1 million dinars in the first half of 2018 to 11.2 million at the end of last June, down 30%.
As for debt, it went up from 34.7 million dinars at December 31, 2018 to 35.1 million in the first half of 2019, posting a slight rise of 1%.
